Racial Variations in PSA and PSA Density Among Men With Negative Prostate Biopsies: A Multicenter Comparative Study of Chinese, African American, and Caucasian American Populations
Cancer Medicine · 2026-11 · 15 (11)
DOI: 10.1002/cam4.72440 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Medicine, online erschienen am 29.10.2026. Verfasst von Zhi Xiong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Prostatic Neoplasms, Prostate. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Projects in Guangzhou, Guangzhou Regional Clinical High-Tech, Major, and Characteristic Technology Projects, Guangdong Medical Research Foundation.
Abstract (Originalsprache)
Background
Prostate‐specific antigen (PSA) and PSA density (PSAD) are widely used for prostate cancer (PCa) screening, but their diagnostic thresholds have not been differentially adjusted for ethnic groups in clinical practice. This multicenter study aimed to establish the distribution of PSA and PSAD in Chinese men without PCa and compare these values with published data from African American (AA) and Caucasian American (CA) men to assess potential racial disparities.
Methods
We analyzed 528 biopsy‐negative Chinese men from two tertiary centers, comparing their age‐adjusted PSA/PSAD with published AA/CA data. Additionally, we compared PSA/PSAD distributions and the proportion of men exceeding the conventional PSA cutoff (4 ng/mL) across racial groups.
Results
PSA levels showed a weak but significant positive correlation with age ( r = 0.121, p = 0.005), whereas PSAD did not ( r = −0.032, p = 0.465). Notably, Chinese men without PCa exhibited significantly higher mean PSA and PSAD than AA and CA men (PSA: 17.28 vs. 7.97 vs. 4.30 ng/mL, p < 0.001; PSAD: 0.28 vs. 0.19 vs. 0.11 ng/mL/mL, p < 0.001). Using a PSA cutoff of 4 ng/mL, the specificity for PCa detection was substantially lower in Chinese men than in AA and CA men at matched sensitivity levels.
Conclusions
This study reveals striking racial differences in baseline PSA and PSAD among men without PCa, with Chinese men demonstrating markedly higher values than AA and CA counterparts. These findings challenge the universal application of current PSA thresholds and underscore the need for race‐specific adjustments to optimize PCa screening accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
- School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
- Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Förderung
- Science and Technology Projects in Guangzhou
- Guangzhou Regional Clinical High-Tech, Major, and Characteristic Technology Projects
- Guangdong Medical Research Foundation
- Start-up funds for scientific research of the Guangzhou First People's Hospital
- National Natural Science Foundation of China
Zitieren
APA
Xiong, Z., Zhou, P., Xu, A., Guo, C., Xiong, S., & Tang, P. (2026). Racial Variations in PSA and PSA Density Among Men With Negative Prostate Biopsies: A Multicenter Comparative Study of Chinese, African American, and Caucasian American Populations. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72440
Vancouver
Xiong Z, Zhou P, Xu A, Guo C, Xiong S, Tang P. Racial Variations in PSA and PSA Density Among Men With Negative Prostate Biopsies: A Multicenter Comparative Study of Chinese, African American, and Caucasian American Populations. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72440
BibTeX
@article{Xiong2026,
author = {Xiong, Zhi and Zhou, Ping and Xu, Abai and Guo, Chaojun and Xiong, Siwei and Tang, Ping},
title = {Racial Variations in PSA and PSA Density Among Men With Negative Prostate Biopsies: A Multicenter Comparative Study of Chinese, African American, and Caucasian American Populations},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {11},
doi = {10.1002/cam4.72440}
}
EUVIMED